Literature DB >> 11762955

Treatment of longstanding active giant cell arteritis with infliximab: report of four cases.

F Cantini1, L Niccoli, C Salvarani, A Padula, I Olivieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11762955     DOI： 10.1002/1529-0131(200112)44:12<2933::aid-art482>3.0.co;2-y

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  45 in total

Review 1.  [Therapy of primary systemic vasculitis].

Authors:  K de Groot; W L Gross; B Hellmich
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

Review 2.  Giant cell arteritis.

Authors:  J M Calvo-Romero
Journal:  Postgrad Med J       Date:  2003-09       Impact factor: 2.401

3.  Methotrexate treatment for giant cell arteritis.

Authors:  Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

Review 4.  New indications for biological therapies.

Authors:  Mariagrazia Catanoso; Nicolò Pipitone; Luca Magnani; Luigi Boiardi; Carlo Salvarani
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

5.  Treatment of refractory temporal arteritis with adalimumab.

Authors:  M Mubashir Ahmed; Eisha Mubashir; Samina Hayat; Marjorie Fowler; Seth Mark Berney
Journal:  Clin Rheumatol       Date:  2006-08-30       Impact factor: 2.980

6.  Infliximab as monotherapy in giant cell arteritis.

Authors:  Imad Uthman; Nadim Kanj; Samir Atweh
Journal:  Clin Rheumatol       Date:  2005-05-18       Impact factor: 2.980

Review 7.  Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.

Authors:  Miguel A Gonzalez-Gay; Carlos Garcia-Porrua; Jose A Miranda-Filloy; Javier Martin
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 8.  Giant cell arteritis: diagnosis and therapeutic management.

Authors:  Miguel A Gonzalez-Gay; Carlos Garcia-Porrua; Jose A Miranda-Filloy
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

9.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; P Emery; E C Keystone; M H Schiff; P L C M van Riel; M E Weinblatt; M H Weisman
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

Review 10.  Advances in the use of biologic agents for the treatment of systemic vasculitis.

Authors:  Sharon A Chung; Philip Seo
Journal:  Curr Opin Rheumatol       Date:  2009-01       Impact factor: 5.006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.